aTYR PHARMA (ATYR) Leases (2019 - 2025)
Historic Leases for aTYR PHARMA (ATYR) over the last 7 years, with Q3 2025 value amounting to $5.6 million.
- aTYR PHARMA's Leases fell 472.71% to $5.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.6 million, marking a year-over-year decrease of 472.71%. This contributed to the annual value of $5.8 million for FY2024, which is 1352.76% down from last year.
- As of Q3 2025, aTYR PHARMA's Leases stood at $5.6 million, which was down 472.71% from $5.7 million recorded in Q2 2025.
- Over the past 5 years, aTYR PHARMA's Leases peaked at $7.2 million during Q4 2022, and registered a low of $827000.0 during Q2 2022.
- For the 5-year period, aTYR PHARMA's Leases averaged around $4.8 million, with its median value being $5.8 million (2024).
- In the last 5 years, aTYR PHARMA's Leases plummeted by 5091.99% in 2022 and then soared by 76082.22% in 2023.
- Over the past 5 years, aTYR PHARMA's Leases (Quarter) stood at $1.3 million in 2021, then soared by 472.22% to $7.2 million in 2022, then fell by 7.21% to $6.7 million in 2023, then fell by 13.53% to $5.8 million in 2024, then decreased by 3.68% to $5.6 million in 2025.
- Its Leases stands at $5.6 million for Q3 2025, versus $5.7 million for Q2 2025 and $5.8 million for Q1 2025.